BRIEF published on 06/28/2024 at 10:01, 4 months 23 days ago Swiss Merchant Group AG Arranges Swiss Mini Bond for Skill Solutions AG Investment Corporate Bond Swiss Merchant Group Skill Solutions Swiss Mini Bond
PRESS RELEASE published on 06/28/2024 at 09:56, 4 months 23 days ago Swiss Merchant Group AG has arranged a Swiss Mini Bond for Skill Solutions AG - ISIN: CH1362686268 Swiss Merchant Group AG arranges Swiss Mini Bond for Skill Solutions AG with CHF 8 million issue volume, 8% coupon rate, and 5-year term. SMG to conduct Swiss road show for investors Swiss Merchant Group AG Corporate Bond Issue Swiss Mini Bond Skill Solutions AG Swiss Road Show
BRIEF published on 06/21/2024 at 09:05, 5 months ago Swiss Merchant Group AG Arranges Corporate Bond for blue8X AG Decarbonization Sustainable Investments Corporate Bond Swiss Merchant Group AG Blue8X AG
PRESS RELEASE published on 06/21/2024 at 09:00, 5 months ago Swiss Merchant Group AG has arranged the bluex AG corporate bond issue with the ISN: CH 1360966472 Swiss Merchant Group AG arranges blue8X AG corporate bond issue ISIN: CH1360966472 to finance acquisitions of solar companies in Switzerland Swiss Merchant Group AG Blue8X AG Corporate Bond Issue CH1360966472 Solar Companies
BRIEF published on 06/14/2024 at 12:56, 5 months 7 days ago Dr. Ingo Mantzke and Expulsion from the Investment Committee of Swiss Merchant Group AG Corporate Governance Advisor Role Dr. Ingo Mantzke Swiss Merchant Group AG Investment Committee
PRESS RELEASE published on 06/14/2024 at 12:51, 5 months 7 days ago Dr. Ingo Mantzke and expulsion from the Investment Committee of Swiss Merchant Group AG Swiss Merchant Group AG clarifies Dr. Ingo Mantzke's role in the Investment Committee. The company separates from him following non-public dissolution of relationship Corporate Governance Dr. Ingo Mantzke Swiss Merchant Group AG Investment Committee Regulated Investor
PRESS RELEASE published on 11/10/2023 at 14:17, 1 year ago Swiss Merchant Group AG issues an 8% Swiss franc bond with a 5-year term and monthly interest payments
PRESS RELEASE published on 08/22/2023 at 18:42, 1 year 2 months ago Swiss Merchant Group AG: Intended Transaction of Cardea Corporate Holdings Inc. and Global Blockchain Acquisition Corp
PRESS RELEASE published on 07/21/2023 at 11:05, 1 year 4 months ago Swiss Merchant Group AG: Misinformation and New Findings from the Evan Group plc Insolvency Petition
PRESS RELEASE published on 07/03/2023 at 10:00, 1 year 4 months ago Swiss Merchant Group AG: Swiss Merchant Group Issue a three years Swiss France 8% Coupon Convertible Loan for its Green-Certificated-Investments
Published on 11/21/2024 at 13:30, 27 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 27 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 57 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 57 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 57 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 21 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 42 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 59 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 37 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 12 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 12 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
